TrialCardiovascular therapeutics2017

Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trial.

Giuseppe Derosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.